Disitamab vedotin (anti-HER2) is an antibody-drug conjugate (ADC) comprising a monoclonal antibody against human epidermal growth factor receptor 2 (HER2) conjugated via a cleavable linker to the cytotoxic agent Monomethyl auristatin E (MMAE). Disitamab vedotin (anti-HER2) enhances antitumor immunity.
Specification: ExactAb™, Recombinant, Validated, Azide Free, Low Endotoxin, Carrier Free, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB183317-SCI_3b10adc34be8a2556e848e525f106fd4.pdf
- UPC:
- 51202407
- Condition:
- New
- Availability:
- 4-8 weeks
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab183317-100μg
- CAS:
- 2136633-23-1
- Product Size:
- 100μg